SCM
DERM icon

Sterling Capital Management’s Journey Medical DERM Stock Holding History

Sterling Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-134
Closed -$628 – 3316
2026
Q1 		$628 Buy
134
+54
+68% +$419 ﹤0.01% 3132
2025
Q4 		$617 Buy
80
+50
+167% +$392 ﹤0.01% 3178
2025
Q3 		$214 Buy
30
+1
+3% +$7 ﹤0.01% 3210
2025
Q2 		$208 Buy
+29
New +$200 ﹤0.01% 3231

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Sterling Capital Management's DERM Position: Q2 2026 in Review

Sterling Capital Management sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 134 shares — an estimated $628 sold.

Sterling Capital Management first reported a position in DERM in Q2 2025 and held it in 4 quarters. The position peaked at $628 in Q1 2026. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Sterling Capital Management reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 134 Journey Medical shares in Q2 2026, an estimated $628.
  • Sterling Capital Management first reported a position in Journey Medical in Q2 2025 and held it in 4 quarters.
  • Sterling Capital Management's Journey Medical position peaked at $628 in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.